
Embecta Corp. – NASDAQ:EMBC
Embecta Corp. stock price today
Embecta Corp. stock price monthly change
Embecta Corp. stock price quarterly change
Embecta Corp. stock price yearly change
Embecta Corp. key metrics
Market Cap | 1.20B |
Enterprise value | 2.54B |
P/E | 15.33 |
EV/Sales | 2.26 |
EV/EBITDA | 11.29 |
Price/Sales | 1.07 |
Price/Book | -1.62 |
PEG ratio | -9.30 |
EPS | 1.10 |
Revenue | 1.13B |
EBITDA | 240.9M |
Income | 64.1M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 6.97% |
Oper. margin | 17.75% |
Gross margin | 65.35% |
EBIT margin | 17.75% |
EBITDA margin | 21.28% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEmbecta Corp. stock price history
Embecta Corp. stock forecast
Embecta Corp. financial statements
$23
Potential upside: 67.27%
Analysts Price target
Financials & Ratios estimates
Mar 2023 | 277.1M | 14M | 5.05% |
---|---|---|---|
Jun 2023 | 286.1M | 15.2M | 5.31% |
Sep 2023 | 281.9M | 6M | 2.13% |
Mar 2024 | 287.2M | 28.9M | 10.06% |
Payout ratio | 44.06% |
---|
2020 | |
---|---|
2021 | |
2022 | 0.52% |
2023 | 3.99% |
2024 |
Mar 2023 | 1210000000 | 2.03B | 167.98% |
---|---|---|---|
Jun 2023 | 1252100000 | 2.06B | 164.64% |
Sep 2023 | 1214400000 | 2.03B | 167.66% |
Mar 2024 | 1199600000 | 1.96B | 164.15% |
Mar 2023 | -13M | -5.8M | -20.7M |
---|---|---|---|
Jun 2023 | -9.3M | -6.8M | -12.2M |
Sep 2023 | 29.6M | -9.2M | -9.7M |
Mar 2024 | 24.3M | -3.4M | -11.8M |
Embecta Corp. alternative data
Aug 2023 | 2,000 |
---|---|
Sep 2023 | 1,900 |
Oct 2023 | 1,900 |
Nov 2023 | 1,900 |
Dec 2023 | 2,000 |
Jan 2024 | 2,200 |
Feb 2024 | 2,200 |
Mar 2024 | 2,200 |
Apr 2024 | 2,200 |
May 2024 | 2,200 |
Jun 2024 | 2,200 |
Jul 2024 | 2,200 |
Embecta Corp. other data
Period | Buy | Sel |
---|---|---|
Aug 2023 | 14325 | 0 |
Sep 2023 | 6233 | 0 |
Feb 2024 | 2000 | 0 |
Quarter | Transcript |
---|---|
Q2 2024 11 May 2024 | Q2 2024 Earnings Call Transcript |
Q1 2024 9 Feb 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 21 Nov 2023 | Q4 2023 Earnings Call Transcript |
Q3 2023 13 Aug 2023 | Q3 2023 Earnings Call Transcript |
-
What's the price of Embecta Corp. stock today?
One share of Embecta Corp. stock can currently be purchased for approximately $13.75.
-
When is Embecta Corp.'s next earnings date?
Unfortunately, Embecta Corp.'s (EMBC) next earnings date is currently unknown.
-
Does Embecta Corp. pay dividends?
Yes, Embecta Corp. pays dividends and its trailing 12-month yield is 2.9% with 44% payout ratio. The last Embecta Corp. stock dividend of undefined was paid on 5 Sep 2025.
-
How much money does Embecta Corp. make?
Embecta Corp. has a market capitalization of 1.20B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.21% to 1.12B US dollars.
-
What is Embecta Corp.'s stock symbol?
Embecta Corp. is traded on the NASDAQ under the ticker symbol "EMBC".
-
What is Embecta Corp.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Embecta Corp.?
Shares of Embecta Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Embecta Corp. have?
As Jul 2024, Embecta Corp. employs 2,200 workers.
-
When Embecta Corp. went public?
Embecta Corp. is publicly traded company for more then 3 years since IPO on 22 Mar 2022.
-
What is Embecta Corp.'s official website?
The official website for Embecta Corp. is embecta.com.
-
Where are Embecta Corp.'s headquarters?
Embecta Corp. is headquartered at 300 Kimball Drive, Parsippany, NJ.
-
How can i contact Embecta Corp.?
Embecta Corp.'s mailing address is 300 Kimball Drive, Parsippany, NJ and company can be reached via phone at +20 18476880.
-
What is Embecta Corp. stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Embecta Corp. in the last 12 months, the avarage price target is $23. The average price target represents a 67.27% change from the last price of $13.75.
Embecta Corp. company profile:

Embecta Corp.
embecta.comNASDAQ
2,200
Drug Manufacturers - Specialty & Generic
Healthcare
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Parsippany, NJ 07054
CIK: 0001872789
ISIN: US29082K1051
CUSIP: 29082K105